Mizuho Maintains Buy on GE HealthCare Techs, Lowers Price Target to $105
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Anthony Petrone maintains a Buy rating on GE HealthCare Techs (NASDAQ:GEHC) but lowers the price target from $110 to $105.

May 01, 2024 | 2:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Mizuho maintains a Buy rating on GE HealthCare Techs but lowers the price target from $110 to $105.
The adjustment in price target by Mizuho reflects a nuanced view on GE HealthCare Techs' valuation, suggesting a slightly less optimistic but still positive outlook. The Buy rating indicates continued confidence in the company's performance, but the lowered price target may temper expectations slightly. This could lead to a neutral short-term impact on the stock as investors digest the implications of the revised target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100